 |
PDBsum entry 4xcu
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Transferase/transferase inhibitor
|
PDB id
|
|
|
|
4xcu
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
References listed in PDB file
|
|
|
Key reference
|
|
|
Title
|
|
First selective small molecule inhibitor of fgfr4 for the treatment of hepatocellular carcinomas with an activated fgfr4 signaling pathway.
|
|
|
Authors
|
|
M.Hagel,
C.Miduturu,
M.Sheets,
N.Rubin,
W.Weng,
N.Stransky,
N.Bifulco,
J.L.Kim,
B.Hodous,
N.Brooijmans,
A.Shutes,
C.Winter,
C.Lengauer,
N.E.Kohl,
T.Guzi.
|
|
|
Ref.
|
|
Cancer Discov, 2015,
5,
424-437.
[DOI no: ]
|
|
|
PubMed id
|
|
|
|
|
|
Abstract
|
|
|
No abstract given.
|
|
|
|
|
|
|
